| 
				The company's upbeat forecast follows that of industry 
				bellwether UnitedHealth Group Inc, which said although demand 
				for deferred procedures was approaching normal levels it had 
				still not increased as feared, leading to lower claims and 
				costs.
 In the first quarter, Anthem's benefit expense ratio - an 
				insurer's spending on claims against the premiums it earns - was 
				86.1%, compared with expectations of 87.8%, according to five 
				analysts polled by Refinitiv.
 
 The company now expects adjusted net income of over $28.40 per 
				share, compared with its prior forecast of more than $28.25 per 
				share.
 
 Excluding items, Anthem earned $8.25 per share, surging past 
				Refinitiv IBES estimates of $7.81 per share.
 
 Net income attributable to shareholders rose to $1.81 billion, 
				or $7.39 per share, in the first quarter ended March 31 from 
				$1.67 billion, or $6.71 per share, a year earlier.
 
 (Reporting by Manas Mishra in Bengaluru; Editing by Anil D'Silva)
 
 
 
 
			[© 2022 Thomson Reuters. All rights 
			reserved.]
 Copyright 2022 Reuters.  All rights reserved. This material may not be published, 
			broadcast, rewritten or redistributed.  
			Thompson Reuters is solely responsible for this content.
 
				 
				  |  |